Featured Research

from universities, journals, and other organizations

Common Delivery System Used In Treating Muscular Dystrophy Through Gene Therapy May Trigger An Immune Response In Mice

Date:
January 24, 2001
Source:
University Of Pennsylvania Medical Center
Summary:
In a study of muscular dystrophy, scientists at the University of Pennsylvania School of Medicine have found that a common delivery system used in treating the disease through gene therapy may trigger an immune response in mice unless it is used in combination with a muscle-specific promoter that localizes the expression of genetic material.

In a study of muscular dystrophy, scientists at the University of Pennsylvania School of Medicine have found that a common delivery system used in treating the disease through gene therapy may trigger an immune response in mice unless it is used in combination with a muscle-specific promoter that localizes the expression of genetic material.

The study findings are published in the new issue of the journal Human Gene Therapy.

“Even when you use low-levels of a promoter that is not restricted to the afflicted area, you run the risk that you will immunize the patient against the very protein you are trying to get made,” said H. Lee Sweeney, PhD, chairman of the Department of Physiology at Penn and lead author of the study. “This is relevant because some of the clinical trials that have been started are not using restricted promoters. The journal wanted to get this message out there.”

In their published findings, the Penn researchers state that it is “crucial” to establish which method should be used before expanding clinical trials.

The scientists used two groups of mice that had been engineered to lack a protein called gamma sarcloc-glycan (gsg) in their muscles, which is the same protein that is missing in muscluar dystrophy (MD).

The researchers administered the protein to both groups of mice by enclosing the gsg in the recombinant adeno-associated virus (rAAV) – a commonly used vector that has been described in previous scientific research as non-immunogenic.

In one group of mice, the rAAV included a cytomegalovirus (CMV) promoter -- which will express the DNA material it carries in any tissue. The results Sweeney found: “Although we didn’t see the immune response in the CMV promoter in a large percentage of the mice – we did see it.”

In the second group of mice, when the rAAV that contained the gsg material was delivered under the control of the muscle creatine kinase promoter – which is muscle-specific -- there was no immune response.

“What we think happens is that if the virus gets into tissues that are very good at presenting foreign proteins to the immune system, then an immune response is generated to any proteins the virus may express,” Sweeney said. “Skeletal muscle (which is affected by MD) is very bad at presenting – we’ve never seen an immune response, as long as the expressed protein is restricted to the skeletal muscle.”

“The issue is: If you put DNA material into a virus that will fix the disease –will it also trigger an immune response?” Sweeney said.

“The answer appears to be – possibly. But as long as you keep the protein in the skeletal muscle and nowhere else, you don’t get an immune response.”

The study was funded by the National Institutes of Health, the Muscular Dystrophy Association and the Association Francaise contre les Myopathies.

Sweeney’s collaborators in the research were: Laurence Cordier, PhD, of Penn’s Department of Physiology; Andrew A. Hack, PhD, and Elizabeth M. McNally, PhD, both of the University of Chicago, and Guang-Ping Gao, PhD; Narendra Chirmule, PhD, and James M. Wilson, MD, PhD, of Penn’s Institute for Human Gene Therapy.


Story Source:

The above story is based on materials provided by University Of Pennsylvania Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University Of Pennsylvania Medical Center. "Common Delivery System Used In Treating Muscular Dystrophy Through Gene Therapy May Trigger An Immune Response In Mice." ScienceDaily. ScienceDaily, 24 January 2001. <www.sciencedaily.com/releases/2001/01/010123075357.htm>.
University Of Pennsylvania Medical Center. (2001, January 24). Common Delivery System Used In Treating Muscular Dystrophy Through Gene Therapy May Trigger An Immune Response In Mice. ScienceDaily. Retrieved July 31, 2014 from www.sciencedaily.com/releases/2001/01/010123075357.htm
University Of Pennsylvania Medical Center. "Common Delivery System Used In Treating Muscular Dystrophy Through Gene Therapy May Trigger An Immune Response In Mice." ScienceDaily. www.sciencedaily.com/releases/2001/01/010123075357.htm (accessed July 31, 2014).

Share This




More Health & Medicine News

Thursday, July 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Xtreme Eating: Your Daily Caloric Intake All On One Plate

Xtreme Eating: Your Daily Caloric Intake All On One Plate

Newsy (July 30, 2014) The Center for Science in the Public Interest released its 2014 list of single meals with whopping calorie counts. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



      Save/Print:
      Share:

      Free Subscriptions


      Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

      Get Social & Mobile


      Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

      Have Feedback?


      Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
      Mobile: iPhone Android Web
      Follow: Facebook Twitter Google+
      Subscribe: RSS Feeds Email Newsletters
      Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins